Lotus Bio Financials
| LBTD Stock | USD 0.01 0.00 0.00% |
Lotus |
Please note, the presentation of Lotus Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Lotus Bio's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Lotus Bio's management manipulating its earnings.
Lotus Bio Stock Summary
Lotus Bio competes with BYD Company, Mercedes Benz, Porsche Automobile, Stellantis, and Volkswagen. Lotus Bio-Technology Development Corp., a bio-technology development company, focuses on refining organic materials, and production of natural consumer related products in China. Lotus Bio-Technology Development Corp. was founded in 2011 and is based in Cave Creek, Arizona. Lotus Bio-Technology is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US54570R1077 |
| Business Address | 28202 North 58th |
| Sector | Media (discontinued effective close of September 28, 2018) |
| Industry | Consumer Discretionary |
| Benchmark | Dow Jones Industrial |
| Website | www.lotusbiotechnologies.com |
| Phone | 480 275 2294 |
| Currency | USD - US Dollar |
Lotus Bio Key Financial Ratios
There are many critical financial ratios that Lotus Bio's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Lotus Bio Technology reports annually and quarterly.Lotus Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Lotus Bio's current stock value. Our valuation model uses many indicators to compare Lotus Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Lotus Bio competition to find correlations between indicators driving Lotus Bio's intrinsic value. More Info.Lotus Bio Technology Development is rated second overall in return on asset category among its peers. It is rated third overall in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Lotus Bio's earnings, one of the primary drivers of an investment's value.Lotus Bio Technology Systematic Risk
Lotus Bio's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Lotus Bio volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was nine with a total number of output elements of fifty-two. The Beta measures systematic risk based on how returns on Lotus Bio Technology correlated with the market. If Beta is less than 0 Lotus Bio generally moves in the opposite direction as compared to the market. If Lotus Bio Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Lotus Bio Technology is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Lotus Bio is generally in the same direction as the market. If Beta > 1 Lotus Bio moves generally in the same direction as, but more than the movement of the benchmark.
Complementary Tools for Lotus Pink Sheet analysis
When running Lotus Bio's price analysis, check to measure Lotus Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Bio is operating at the current time. Most of Lotus Bio's value examination focuses on studying past and present price action to predict the probability of Lotus Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Bio's price. Additionally, you may evaluate how the addition of Lotus Bio to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |